Allotex is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Allotex develops allograft inlays and onlays used in reconstructive surgery procedures to provide regenerative medicine solutions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.